The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

This bipartisan legislation prevents further cuts, provides a modest inflationary adjustment to help ease the cost of care, ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid medication for treating moderate to severe acute pain in adults. Journavx, approved ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.